Detalhe da pesquisa
1.
Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries.
Drug Discov Today
; 17(15-16): 861-8, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22569182
2.
Recent clinical trials of mTOR-targeted cancer therapies.
Rev Recent Clin Trials
; 6(1): 24-35, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20868343
3.
Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest.
J Biol Chem
; 277(30): 27449-67, 2002 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-11956189